ITGA2B Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test
Comprehensive Genetic Analysis for Neonatal Bleeding Disorders
The ITGA2B Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for families affected by neonatal bleeding disorders. This advanced molecular test specifically targets the ITGA2B gene, which encodes the αIIb subunit of the αIIbβ3 integrin receptor complex essential for platelet aggregation and clot formation.
What Does This Test Measure?
This sophisticated genetic analysis utilizes next-generation sequencing (NGS) technology to comprehensively examine the ITGA2B gene for pathogenic variants associated with neonatal alloimmune thrombocytopenia (NAIT). The test detects:
- Single nucleotide variants (SNVs) and small insertions/deletions
- Copy number variations (CNVs) affecting gene function
- Regulatory region mutations impacting gene expression
- Inheritance patterns of ITGA2B gene mutations
Who Should Consider This Test?
This genetic test is recommended for individuals and families experiencing:
- Unexplained neonatal bleeding or bruising
- Family history of platelet disorders
- Recurrent pregnancy losses with suspected immune causes
- Previous infants with low platelet counts at birth
- Planning for future pregnancies with known platelet antigen incompatibility
- Suspected Glanzmann thrombasthenia or related disorders
Clinical Benefits of Testing
Undergoing the ITGA2B genetic test provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out genetic causes of neonatal thrombocytopenia
- Family Planning Guidance: Enables informed reproductive decisions
- Treatment Optimization: Guides appropriate therapeutic interventions
- Risk Assessment: Identifies carrier status in family members
- Prenatal Management: Supports specialized obstetric care planning
Understanding Your Test Results
Our comprehensive genetic report includes detailed interpretation by board-certified genetic specialists:
- Positive Result: Identifies specific ITGA2B gene mutation with clinical significance explanation
- Negative Result: No pathogenic variants detected in the analyzed regions
- Variant of Uncertain Significance: Genetic changes requiring further clinical correlation
- Carrier Status: Information about inheritance patterns and family risk assessment
Test Pricing Information
| Test Description | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures accessible genetic testing services nationwide.
Schedule Your Genetic Test Today
Take the first step toward understanding your genetic health. Our expert team is ready to assist you with comprehensive genetic counseling and testing services. Contact us now to schedule your appointment or learn more about our advanced diagnostic capabilities.
Call or WhatsApp: +1(267) 388-9828
Book your ITGA2B Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test today and gain valuable insights into your family’s genetic health. Our dedicated genetic specialists are committed to providing accurate results and personalized guidance for your unique healthcare needs.
